ARANX
Price
$25.78
Change
+$0.05 (+0.19%)
Updated
Jul 25 closing price
Net Assets
1.39B
FLMFX
Price
$9.70
Change
+$0.04 (+0.41%)
Updated
Jul 25 closing price
Net Assets
1.02B
Interact to see
Advertisement

ARANX vs FLMFX

Header iconARANX vs FLMFX Comparison
Open Charts ARANX vs FLMFXBanner chart's image
Horizon Active Risk Assist® Investor
Price$25.78
Change+$0.05 (+0.19%)
VolumeN/A
Net Assets1.39B
Meeder Muirfield Retail
Price$9.70
Change+$0.04 (+0.41%)
VolumeN/A
Net Assets1.02B
ARANX vs FLMFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ARANX vs. FLMFX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARANX is a Buy and FLMFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ARANX has more cash in the bank: 1.4B vs. FLMFX (1.02B). FLMFX pays higher dividends than ARANX: FLMFX (0.90) vs ARANX (0.51). ARANX was incepted earlier than FLMFX: ARANX (11 years) vs FLMFX (37 years). ARANX (1.28) is less costly to investors than FLMFX (1.20). FLMFX is a more actively managed with annual turnover of: 312.00 vs. ARANX (66.00). ARANX (2500) and FLMFX (2500) have matching initial minimum investment requirements. ARANX annual gain was more profitable for investors over the last year : 1.36 vs. FLMFX (-4.39). FLMFX return over 5 years is better than : 43.45 vs. ARANX (37.95).
ARANXFLMFXARANX / FLMFX
Total Expense Ratio1.281.20107%
Annual Report Gross Expense Ratio1.281.20107%
Fund Existence11 years37 years-
Gain YTD7.3276.357115%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.4B1.02B136%
Annual Yield % from dividends0.510.9056%
Returns for 1 year1.36-4.39-31%
Returns for 3 years25.0620.62122%
Returns for 5 years37.9543.4587%
Returns for 10 years34.4848.5571%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LXEO4.130.46
+12.53%
Lexeo Therapeutics
TGT106.050.23
+0.22%
Target Corp
CYTK37.18-0.13
-0.35%
Cytokinetics
CRON2.05-0.02
-0.97%
Cronos Group
MOB3.54-0.14
-3.80%
Mobilicom Limited